Spotlight on Multiple Sclerosis
Showcasing the latest news and clinical breakthroughs in care, Spotlight on Multiple Sclerosis shines an educational beacon for healthcare professionals dedicated to improving patients’ quality of life and outcomes.
Here you’ll find leading neurologists and other allied healthcare professionals sharing research updates and novel insights on collaborative, evidence-based practices to slow the disease course, treat relapses, manage symptoms, and improve function and safety.
16-30 of 37
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiersStudying Cortical Lesions in MS: Future Research Directions
Michael G. Dwyer, PhD
Monitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
NeuroFrontiersMonitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
Advances in MS Management: Current and Future Directions
NeuroFrontiersAdvances in MS Management: Current and Future Directions
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiersFatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
NeuroFrontiersMS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
Brian P. McDonough, MD, FAAFP
John R. Corboy, MD
Overheating and MS: Exploring New Approaches to Exercise Comfort
NeuroFrontiersOverheating and MS: Exploring New Approaches to Exercise Comfort
Victoria Leavitt, PhD
- advertisement
Investigating the Prevalence of Comorbidities in MS Clinical Trials
NeuroFrontiersInvestigating the Prevalence of Comorbidities in MS Clinical Trials
Ashley Baker, MSN, PMHNP
Amber Salter, PhD
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
NeuroFrontiersFamily Planning Clinical Considerations for Patients with Multiple Sclerosis
Ashley Baker, MSN, PMHNP
Anna A. Shah, MD
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
NeuroFrontiersAdverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
Andrew Wilner, MD, FACP, FAAN
Carri Polick, PhD, RN
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
NeuroFrontiersMS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
Jennifer Caudle, DO, FACOFP
Mitzi Joi Williams, MD
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
NeuroFrontiersMind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
Charles Turck, PharmD, BCPS, BCCCP
Anibal Chertcoff, MD
- advertisement
Discussing Disparities in MS Care for Underrepresented Populations
NeuroFrontiersDiscussing Disparities in MS Care for Underrepresented Populations
Charles Turck, PharmD, BCPS, BCCCP
Tirisham V. Gyang, MD
Gopika Govindan Kutty, MD
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
NeuroFrontiersDiscussing the Latest in MS Treatment and Disease-Modifying Therapies
Charles Turck, PharmD, BCPS, BCCCP
Jay Avasarala, MD, PhD
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiersDiagnosing Suspected MS: A Review of the Updated Guidelines
Andrew Wilner, MD, FACP, FAAN
Eoin Flanagan, MB, BCh
